Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?
作者信息
Dick A D
机构信息
Centenary Institute of Cancer Medicine and Cell Biology, Sydney, Australia.
出版信息
Br J Ophthalmol. 1995 Jan;79(1):81-8. doi: 10.1136/bjo.79.1.81.
Abstract
摘要
相似文献
1
Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?自身免疫性疾病特异性免疫疗法的实验方法：内源性后葡萄膜炎的未来治疗？
Br J Ophthalmol. 1995 Jan;79(1):81-8. doi: 10.1136/bjo.79.1.81.
2
Experimental autoimmune uveoretinitis: a model system for immunointervention: a review.实验性自身免疫性葡萄膜视网膜炎：免疫干预的模型系统：综述
Curr Eye Res. 1992;11 Suppl:33-40. doi: 10.3109/02713689208999509.
3
Tolerance--will it end in tears?耐受性——会以悲剧收场吗？
Eye (Lond). 1997;11 ( Pt 4):441-2. doi: 10.1038/eye.1997.122.
4
New therapeutic options in uveitis.葡萄膜炎的新治疗选择。
Eye (Lond). 1997;11 ( Pt 2):222-6. doi: 10.1038/eye.1997.56.
5
Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.T细胞介导疾病的实验性肽免疫疗法中涉及的免疫机制。
Crit Rev Immunol. 2000;20(6):451-69.
6
7
T lymphocyte effector mechanisms in the retina in posterior uveitis.后葡萄膜炎中视网膜的T淋巴细胞效应机制。
Eye (Lond). 1994;8 ( Pt 1):60-5. doi: 10.1038/eye.1994.11.
8
Selective targets for immunotherapy in autoimmune disease.自身免疫性疾病中免疫治疗的选择性靶点。
Chem Immunol. 1995;60:20-31.
9
Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis.系统评价免疫抑制剂和生物疗法治疗自身免疫性后部葡萄膜炎的疗效。
Semin Arthritis Rheum. 2011 Feb;40(4):314-23. doi: 10.1016/j.semarthrit.2010.05.008. Epub 2010 Jul 24.
10
Immune therapy for autoimmune diseases.自身免疫性疾病的免疫疗法。
Science. 2004 Jul 9;305(5681):212-6. doi: 10.1126/science.1099896.
引用本文的文献
1
Adrenomedullin-RAMP2 System Modulates Inflammation and Tissue Repair in Experimental Autoimmune Uveitis Via T-Cell and M2 Macrophage Regulation.肾上腺髓质素-RAMP2系统通过调节T细胞和M2巨噬细胞来调控实验性自身免疫性葡萄膜炎中的炎症和组织修复。
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):12. doi: 10.1167/iovs.66.6.12.
2
Cytokines and Biologics in non-infectious autoimmune uveitis: bench to bedside.细胞因子和生物制剂在非感染性自身免疫性葡萄膜炎中的应用：从基础到临床。
Indian J Ophthalmol. 2014 Jan;62(1):74-81. doi: 10.4103/0301-4738.126187.
3
Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.那他滨（FTY720）的治疗剂量可防止细胞浸润，迅速抑制眼部炎症，并维持血眼屏障。
Am J Pathol. 2012 Feb;180(2):672-81. doi: 10.1016/j.ajpath.2011.10.008. Epub 2011 Nov 24.
4
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.系统性和局部抗 C5 治疗可降低实验性自身免疫性葡萄膜炎的疾病严重程度。
Clin Exp Immunol. 2010 Mar;159(3):303-14. doi: 10.1111/j.1365-2249.2009.04070.x. Epub 2009 Dec 4.
5
Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.白塞病眼部症状管理的当前趋势
Clin Ophthalmol. 2009;3:567-79. doi: 10.2147/opth.s4445. Epub 2009 Oct 19.
6
Molecular analysis of resolving immune responses in uveitis.葡萄膜炎中消退性免疫反应的分子分析
Clin Exp Immunol. 1999 Sep;117(3):455-61. doi: 10.1046/j.1365-2249.1999.00993.x.
7
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.慢性葡萄膜炎的免疫抑制治疗：优化类固醇和环孢素A治疗方案
Br J Ophthalmol. 1997 Dec;81(12):1107-12. doi: 10.1136/bjo.81.12.1107.
8
Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.光感受器间类视黄醇结合蛋白在Lewis大鼠中是一种有效的免疫耐受原：实验性自身免疫性葡萄膜视网膜炎的抑制是视网膜抗原特异性的。
Br J Ophthalmol. 1997 Jan;81(1):61-7. doi: 10.1136/bjo.81.1.61.
本文引用的文献
1
Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens.经鼻给予视网膜抗原可抑制实验性过敏性葡萄膜视网膜炎中的炎症反应。关于经鼻给予视网膜抗原诱导耐受的初步报告。
Br J Ophthalmol. 1993 Mar;77(3):171-5. doi: 10.1136/bjo.77.3.171.
2
Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction.用雷帕霉素（一种淋巴细胞生长因子信号转导抑制剂）治疗大鼠自身免疫性葡萄膜视网膜炎。
Curr Eye Res. 1993 Feb;12(2):197-203. doi: 10.3109/02713689308999487.
3
The use of monoclonal antibodies to achieve immunological tolerance.使用单克隆抗体来实现免疫耐受。
Immunol Today. 1993 Jun;14(6):247-51. doi: 10.1016/0167-5699(93)90040-R.
4
The paradoxical effect of tumor necrosis factor alpha (TNF-alpha) in endotoxin-induced uveitis.肿瘤坏死因子α（TNF-α）在内毒素诱导的葡萄膜炎中的矛盾效应。
Invest Ophthalmol Vis Sci. 1993 Sep;34(10):2911-7.
5
Cytokines: the good, the bad, and the unknown.细胞因子：有益的、有害的及未知的。
Invest Ophthalmol Vis Sci. 1993 Jul;34(8):2389-91.
6
7
Adhesion molecule expression in acute and fibrotic sympathetic ophthalmia.急性和纤维化交感性眼炎中黏附分子的表达
Curr Eye Res. 1993 Oct;12(10):923-34. doi: 10.3109/02713689309020399.
8
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease.TH2激活细胞可预防实验性自身免疫性葡萄膜视网膜炎，这是一种依赖TH1的自身免疫性疾病。
Eur J Immunol. 1993 Dec;23(12):3096-103. doi: 10.1002/eji.1830231208.
9
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.用抗肿瘤坏死因子α嵌合单克隆抗体治疗类风湿性关节炎。
Arthritis Rheum. 1993 Dec;36(12):1681-90. doi: 10.1002/art.1780361206.
10
A single amino acid substitution in core residues of S-antigen prevents experimental autoimmune uveitis.S抗原核心残基中的单个氨基酸取代可预防实验性自身免疫性葡萄膜炎。
J Immunol. 1994 May 1;152(9):4699-705.
Zotero 插件